Show simple item record

dc.contributor.authorNajjar, Abdulkarim
dc.contributor.authorPunt, Ans
dc.contributor.authorWambaugh, John
dc.contributor.authorPaini, Alicia
dc.contributor.authorEllison, Corie
dc.contributor.authorFragki, Styliani
dc.contributor.authorBianchi, Enrica
dc.contributor.authorZhang, Fagen
dc.contributor.authorWesterhout, Joost
dc.contributor.authorMueller, Dennis
dc.contributor.authorLi, Hequn
dc.contributor.authorShi, Quan
dc.contributor.authorGant, Timothy W
dc.contributor.authorBotham, Phil
dc.contributor.authorBars, Rémi
dc.contributor.authorPiersma, Aldert
dc.contributor.authorvan Ravenzwaay, Ben
dc.contributor.authorKramer, Nynke I
dc.date.accessioned2022-09-12T17:10:04Z
dc.date.available2022-09-12T17:10:04Z
dc.date.issued2022-09-05
dc.identifier.pmid36063173
dc.identifier.doi10.1007/s00204-022-03356-5
dc.identifier.urihttp://hdl.handle.net/10029/626082
dc.language.isoenen_US
dc.rights© 2022. The Author(s).
dc.subjectIVIVEen_US
dc.subjectNAMsen_US
dc.subjectPBK modelsen_US
dc.subjectRegulatory acceptanceen_US
dc.subjectRisk assessmenten_US
dc.titleTowards best use and regulatory acceptance of generic physiologically based kinetic (PBK) models for in vitro-to-in vivo extrapolation (IVIVE) in chemical risk assessment.en_US
dc.typeArticleen_US
dc.identifier.eissn1432-0738
dc.identifier.journalArchives of toxicology 2022; 96(12):3407-3419en_US
dc.source.journaltitleArchives of toxicology
dc.source.countryGermany


This item appears in the following Collection(s)

Show simple item record